POSB73 Cost-Minimization Analysis for Subcutaneous Daratumumab in the Treatment of Multiple Myeloma in Italy
Jan 1, 2022, 00:00 AM
10.1016/j.jval.2021.11.346
https://www.valueinhealthjournal.com/article/S1098-3015(21)02141-0/fulltext
Section Title :
Section Order :
11122
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(21)02141-0&doi=10.1016/j.jval.2021.11.346